Evidence map›Paper›PMID 32078014›Full record

ArticleEuropean radiology2020

Vascular habitat analysis based on dynamic susceptibility contrast perfusion MRI predicts IDH mutation status and prognosis in high-grade gliomas.

Hao Wu, Haipeng Tong, Xuesong Du, Hong Guo, Qiang Ma, Yulong Zhang, Xiaoyue Zhou, Heng Liu, Sunan Wang, Jingqin Fang and 1 more

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04908267 (To Determine Whether the Habitats Created by the Preoperative or Postoperative Multiparametric MRI Can Predict IDH Mutation Status, Prognosis, Recurrence or Intracranial Distant Recurrence of the Patients With High-grade Gliomas), which is not on this map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04908267 unknown statusnot on this mapstarted 2022, after this paper: background citation

To Determine Whether the Habitats Created by the Preoperative or Postoperative Multiparametric MRI Can Predict IDH Mutation Status, Prognosis, Recurrence or Intracranial Distant Recurrence of the Patients With High-grade Gliomas

TypeobservationalSponsorWeiguo ZhangRan2022 to 2024Enrolled100ConditionsHigh-grade Glioma
3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. MRI-based habitat imaging predicts high-risk molecular subtypes and early risk assessment of lower-grade gliomas.Cancer imaging : the official publication of the International Cancer Imaging Society · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Hao Wu *Department of Radiology, Army Medical Center of PLA, Army Medical University, 10# Changjiangzhilu, Chongqing, 400042, People's Republic of China.
Haipeng Tong *Department of Radiology, Army Medical Center of PLA, Army Medical University, 10# Changjiangzhilu, Chongqing, 400042, People's Republic of China.
Xuesong DuDepartment of Radiology, Army Medical Center of PLA, Army Medical University, 10# Changjiangzhilu, Chongqing, 400042, People's Republic of China.
Hong GuoDepartment of Radiology, Army Medical Center of PLA, Army Medical University, 10# Changjiangzhilu, Chongqing, 400042, People's Republic of China.
Qiang MaDepartment of Pathology, Army Medical Center of PLA, Army Medical University, 10# Changjiangzhilu, Chongqing, 400042, People's Republic of China.
Yulong ZhangDepartment of Radiology, Army Medical Center of PLA, Army Medical University, 10# Changjiangzhilu, Chongqing, 400042, People's Republic of China.
Xiaoyue ZhouMR Collaboration, Siemens Healthineers Ltd., Shanghai, China.
Heng LiuDepartment of Radiology, Army Medical Center of PLA, Army Medical University, 10# Changjiangzhilu, Chongqing, 400042, People's Republic of China.
Sunan WangDepartment of Radiology, Army Medical Center of PLA, Army Medical University, 10# Changjiangzhilu, Chongqing, 400042, People's Republic of China.
Jingqin FangDepartment of Radiology, Army Medical Center of PLA, Army Medical University, 10# Changjiangzhilu, Chongqing, 400042, People's Republic of China. jingqin0405@163.com.
Weiguo ZhangDepartment of Radiology, Army Medical Center of PLA, Army Medical University, 10# Changjiangzhilu, Chongqing, 400042, People's Republic of China. wgzhang01@163.com.
Army Medical University · CNSiemens (China) · CN

Funding

National Key R&D Program of China 2018YFC0115004National Natural Science Foundation of China 81571660National Natural Science Foundation of China 81871421
6 · The paper itself

Abstract

objectiveThe current study aimed to evaluate the clinical practice for hemodynamic tissue signature (HTS) method in IDH genotype prediction in three groups derived from high-grade gliomas.

methodsPreoperative MRI examinations of 44 patients with known grade and IDH genotype were assigned into three study groups: glioblastoma multiforme, grade III, and high-grade gliomas. Perfusion parameters were analyzed and were used to automatically draw the four reproducible habitats (high-angiogenic enhancing tumor habitats, low-angiogenic enhancing tumor habitats, infiltrated peripheral edema habitats, vasogenic peripheral edema habitats) related to vascular heterogeneity. These four habitats were then compared between inter-patient with IDH mutation and their wild-type counterparts at these three groups, respectively. The discriminating potential for HTS in assessing IDH mutation status prediction was assessed by ROC curves.

resultsCompared with IDH wild type, IDH mutation had significantly decreased relative cerebral blood volume (rCBV) at the high-angiogenic enhancing tumor habitats and low-angiogenic enhancing tumor habitats. ROC analysis revealed that the rCBVs in habitats had great ability to discriminate IDH mutation from their wild type in all groups. In addition, the Kaplan-Meier survival analysis yielded significant differences for the survival times observed from the populations dichotomized by low (< 4.31) and high (> 4.31) rCBV in the low-angiogenic enhancing tumor habitat.

conclusionsThe HTS method has been proven to have high prediction capabilities for IDH mutation status in high-grade glioma patients, providing a set of quantifiable habitats associated with tumor vascular heterogeneity. KEY POINTS: • The HTS method has a high accuracy for molecular stratification prediction for all subsets of HGG. • The HTS method can give IDH mutation-related hemodynamic information of tumor-infiltrated and vasogenic edema. • IDH-relevant rCBV difference in habitats will be a great prognosis factor in HGG.

Indexed as

MutationBrain NeoplasmsCerebral Blood VolumeDNADNA Mutational AnalysisFemaleGlioblastomaHumansIsocitrate DehydrogenaseMagnetic Resonance ImagingMaleMiddle AgedPrognosisDNAIsocitrate DehydrogenaseGlioblastomaHemodynamicsIsocitrate dehydrogenasePrognosis

Identifiers

PMID32078014
OpenAlexW3007230112

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.